Mr. Mucus helps Reckitt dominate cough-and-cold space

What's the key to landing your brand on the leaderboard of cough-and-cold meds? Mr. Mucus, apparently. The Reckitt Benckiser spokes-character has propelled Mucinex to three of the top four slots on a new list of preferred OTC products, according to online data-analysis company Treato. More from FiercePharmaMarketing

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Johnson & Johnson is chasing giants in its play for psoriatic arthritis with Tremfya. Strong data could help the newcomer convince the FDA.

Besting AbbVie's megablockbuster Humira is no laughing matter, but now Eli Lilly's Taltz has doubled up on head-to-head wins.